tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market
Want to see BRNS full AI Analyst Report?

Barinthus Biotherapeutics (BRNS) Technical Analysis

113 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Barinthus Biotherapeutics is a Sell.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 0.60, while Barinthus Biotherapeutics’s (BRNS) share price is $0.6, making it a Buy.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 0.61, while Barinthus Biotherapeutics’s (BRNS) share price is $0.6, making it a Buy.

Barinthus Biotherapeutics (BRNS) Pivot Points

Aug 24, 2026, 08:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.59
0.60
0.61
0.62
0.62
0.63
0.63
Fibonacci
0.60
0.61
0.61
0.62
0.62
0.62
0.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Barinthus Biotherapeutics (BRNS) Moving Averages

Aug 24, 2026, 08:57 PM
Period
Simple
Exponential
MA5
0.61Buy
0.61Buy
MA10
0.60Buy
0.60Buy
MA20
0.58Buy
0.60Buy
MA50
0.62Sell
0.61Buy
MA100
0.63Sell
0.64Sell
MA200
0.67Sell
0.75Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 0.60, while Barinthus Biotherapeutics’s (BRNS) share price is $0.6, making it a Buy.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 0.64, while Barinthus Biotherapeutics’s (BRNS) share price is $0.6, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.6 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 0.62, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.6 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 0.63, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.6 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 0.67, creating a Sell signal.

Barinthus Biotherapeutics (BRNS) Technical Indicators

Aug 24, 2026, 08:57 PM
Name
Value
Implied Action
RSI (14)
54.12
Neutral
STOCH (9,6)
54.55
Neutral
STOCHRSI (14)
54.55
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
12.13
Buy
Williams %R
-36.36
Buy
CCI (14)
133.28
Sell
ATR (14)
0.05
-
Ultimate Oscillator
37.74
Neutral
ROC
3.33
Buy
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 54.12, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 12.13, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is 133.28, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is 3.33, creating a Buy signal.

FAQ

Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Buy.
    What is BRNS’s RSI (14)?
    BRNS’s RSI (14) is 54.12, which suggests BRNS is a Neutral.
      What is BRNS’s MACD?
      BRNS’s MACD is >-0.01, which suggests BRNS is a Sell.
        What is BRNS’s 5-day moving average?
        BRNS’s 5-day moving average is 0.61, which suggests BRNS is a Buy.
          What is BRNS’s 20-day moving average?
          BRNS 20-day moving average is 0.58, which suggests BRNS is a Buy.
            What is BRNS’s 50-day moving average?
            BRNS’s 50-day moving average is 0.62, which suggests BRNS is a Sell.
              What is BRNS’s 200-day moving average?
              BRNS’s 200-day moving average is 0.67, which suggests BRNS is a Sell.
                What is BRNS’s Williams % R (14)?
                BRNS’s Williams % R (14) is -36.36, which suggests BRNS is a Buy.
                  What is BRNS’s CCI (14)?
                  BRNS’s CCI (14) is 133.28, which suggests BRNS is a Sell.